TITLE:
Study Evaluating DVS-233 SR in Adult Outpatients With Major Depressive Disorder

CONDITION:
Depression

INTERVENTION:
DVS-233 SR

SUMMARY:

      The main objective of this study is to compare the antidepressant efficacy and safety of
      DVS-233 SR versus placebo in adult outpatients with Major Depressive Disorder.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        Inclusion Criteria:

          -  Outpatients

          -  Men and women age 18 years of age and older

          -  Women of childbearing potential participating in the study must have a negative serum
             pregnancy test result at screening and use a medically acceptable form of
             contraception

        Exclusion Criteria:

          -  Treatment with DVS-233 SR at any time in the past

          -  Treatment with venlafaxine (immediate release [IR] or extended release [ER]) within
             90 days of study day 1

          -  Known hypersensitivity to venlafaxine (IR or ER)

          -  Significant risk of suicide based on clinical judgment, including common
      
